Cuban institute urges heightened precautions against infections

The director of Cuba’s Institute of Hematology and Immunology asked patients being treated for hematological and immunological disorders to strengthen preventive measures amid the circulation of several communicable diseases. The warning places that group at the center of a preventive recommendation and links it to the country’s described health situation. The material does not specify the extent of transmission or list every illness referenced.

Wilfredo Roque García, identified as director of the Dr. José Manuel Ballester Santovenia Institute of Hematology and Immunology, issued the call during an appearance on Cuban television. His remarks convey a recommendation aimed specifically at people with hematological and immunological conditions rather than a general instruction for the entire population. The known message focuses on strengthening prevention.

The warning mentions the circulation of several communicable diseases and says the patients identified should pay attention to prevention. The coverage also refers to dengue and other infections, as well as possible complications for that group. No specific measures, symptoms, case figures or affected territories are detailed here, so the established scope is limited to the warning and the diseases mentioned.

The notice focuses on the relationship between communicable diseases and the health of hematological and immunological patients. The recommendation is to reinforce prevention while those illnesses circulate. The available information does not attribute the call to an institution other than the institute led by Roque García, provide a date for the television appearance or identify protocol changes or additional official measures.

The central point of the televised remarks is prevention for people treated by the Institute of Hematology and Immunology. Its director’s call concerns several communicable diseases and seeks stronger precautions among that group amid their circulation. Without details on particular measures or figures, the warning remains limited to that recommendation and the patients it addresses.